Company Overview - Marcus (MCS) is expected to report a year-over-year decline in earnings, with a projected earnings per share (EPS) of $0.07, reflecting a decrease of 46.2% compared to the previous year [3] - Revenues for the quarter are anticipated to be $184.56 million, which is a 2% decline from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on February 26, and if the results exceed expectations, the stock may experience an upward movement; conversely, missing expectations could lead to a decline [2] - The consensus EPS estimate has been revised 2.14% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model indicates that the Most Accurate Estimate for Marcus is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] - The stock currently holds a Zacks Rank of 4 (Sell), complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Marcus was expected to post earnings of $0.43 per share but delivered $0.42, resulting in a surprise of -2.33% [13] - Over the past four quarters, the company has beaten consensus EPS estimates two times [14] Industry Context - In the Zacks Leisure and Recreation Services industry, Life Time Group Holdings, Inc. (LTH) is expected to report earnings of $0.32 per share, reflecting a year-over-year increase of 18.5% [18] - Life Time Group Holdings anticipates revenues of $740.38 million, which is an 11.6% increase from the previous year [18] - Despite a recent downward revision of 1.5% in the consensus EPS estimate for Life Time Group Holdings, it has an Earnings ESP of +6.35% [19]

Core Viewpoint - Antimony Resources Corp. has successfully expanded and outlined significant antimony stibnite mineralization at the Marcus (West) Zone, with further mineralization exposed through trenching [1][2]. Group 1: Mineralization Discovery - Continued trenching in the Marcus (West) Zone has effectively expanded the area of mineralization, leading to the discovery of new mineralized zones [2]. - The newly discovered mineralization can be easily tested by shallow drilling, with the potential to change drilling direction to optimize results [3][5]. Group 2: Exploration Program - The exploration program for 2026 includes a 10,000-meter definition drilling on the Main Zone, along with soil sampling and prospecting [7]. - Drilling is set to commence immediately on the Marcus (West) Zone, with plans to complete up to six shallow drill holes at depths of 30 to 50 meters [8]. Group 3: Historical Data and Potential - The Central Zone previously returned significant results, including 2.90% Sb over 8.18 meters, with higher grades of 5.79% Sb over 1.75 meters and 8.47% over 1.53 meters [8]. - The Bald Hill project is recognized as a high-grade antimony deposit, with drilling outlining a deposit over 700 meters long and to a depth of at least 350 meters, with average grades of 3% to 4% antimony [14]. Group 4: Company Overview - Antimony Resources Corp. is focused exclusively on antimony exploration and development, aiming to become a significant North American producer [12]. - The management team has extensive experience in financing, exploration, development, and mining, positioning the company for growth in the antimony sector [12].

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to report that Antimony Resources Corp. (CSE-ATMY, OTCQB-ATMYF, FSE-K8JO) have announced the discovery of massive stibnite (antimony) on the now labeled Marcus (West) Zone of the Bald Hill property in New Brun ...

Core Insights - Jyong Biotech Ltd. has successfully completed a Phase II clinical trial for its lead candidate, MCS-8, demonstrating significant efficacy in prostate cancer prevention and potential metabolic benefits [2][3][4] Clinical Efficacy - The Phase II trial involved over 700 high-risk subjects and showed a statistically significant 27.3% reduction in overall prostate cancer incidence in the MCS-8 group compared to placebo [3] - There was a 17.1% reduction in high-grade prostate cancer incidence, which is critical as high-grade malignancies are the main cause of prostate cancer mortality [3] - Further analysis indicated a 35.2% reduction in positive biopsy cores and a 24.4% reduction in cancer-positive areas within those cores, suggesting MCS-8's effectiveness in reducing tumor burden [4] Metabolic Benefits - Patients treated with MCS-8 exhibited a statistically significant reduction in total cholesterol (P = 0.036) and improvements in lipid profiles, including decreased triglycerides (P = 0.05) and LDL levels (P = 0.018), along with increased HDL (P = 0.003) [4] - In contrast, the placebo group showed a significant rise in fasting glucose (P = 0.022), indicating MCS-8's potential in addressing metabolic dysregulation associated with prostate cancer [4] Safety Profile - The Phase II study indicated a favorable safety profile for MCS-8, with no serious adverse events reported and no negative impacts on blood pressure, liver, or kidney function over two years [5] - Analysis of Lactate Dehydrogenase (LDH) levels showed no significant increase in the MCS-8 group, suggesting cytoprotection and a lack of cellular toxicity [6] Commercialization Strategy - Jyong Biotech has initiated strategic partnerships in Asia, including a non-binding Letter of Intent with a South Korean pharmaceutical company for the in-licensing of MCS-2, aimed at navigating regulatory landscapes [7] - A Memorandum of Understanding has also been established with a pharmaceutical distributor in Vietnam to explore the regulatory and commercial pathway for MCS-2, targeting a market with increasing demand for urological therapeutics [8] Management Perspective - The Chairwoman and CEO of Jyong Biotech emphasized the transformation of the company into one with clinically validated assets, highlighting the dual benefits of MCS-8 in reducing cancer incidence and improving metabolic health [9]

MILWAUKEE--(BUSINESS WIRE)--Marcus Corporation (NYSE: MCS) today announced it will report results for the fourth quarter and full year of fiscal 2025 prior to the stock market open on Thursday, February 26, 2026. The release will be followed by a conference call at 10:00 a.m. Central/11:00 a.m. Eastern time. Participants may listen to the call live on the internet through the investor relations section of the company's website: investors.marcuscorp.com, or by dialing 1- 646-844-6383 and enterin. ...

Core Viewpoint - Antimony Resources Corp. has announced the expansion of stibnite mineralization at the Marcus (West) Zone, indicating a potential new mineralization area separate from the Main Zone, with further exploration planned for 2026 [1]. Group 1: Mineralization Discovery - The Marcus (West) Zone has revealed stibnite mineralization over a distance of 25 meters, believed to be distinct from the Main Zone [1]. - Trenching and sampling are planned for the newly discovered Marcus (West) Zone and the Bald Hill South mineralization in the upcoming exploration season [1]. Group 2: Drilling Program - A 2026 Definition Drilling Program has commenced at the Bald Hill Main Zone, utilizing two drill rigs, with a third rig to be added in early February [5]. - The drilling aims to sample the Bald Hill Main Zone over a distance of 600 meters and to a depth of at least 300 meters, with the goal of calculating a Maiden Resource for the Bald Hill Project [5]. Group 3: Project Potential - The Bald Hill project is recognized as a high-grade antimony deposit, with drilling outlining a deposit over 700 meters long, averaging 3 to 4 meters in width and grades of 3% to 4% antimony [10]. - The estimated potential quantity from the 2025 Technical Report is approximately 2.7 million tonnes with a grade between 3% and 4% antimony [10].

Core Insights - The article provides a comprehensive evaluation of Netflix in comparison to its competitors in the Entertainment industry, focusing on financial indicators, market positioning, and growth potential [1] Company Overview - Netflix operates a single business model centered around its streaming service, boasting over 300 million subscribers globally and the largest television entertainment subscriber base in the U.S. and internationally [2] - The company has expanded its revenue streams by introducing ad-supported subscription plans in 2022, diversifying its income beyond traditional subscription fees [2] Financial Performance - Netflix's Price to Earnings (P/E) ratio stands at 33.02, which is 0.52x lower than the industry average, suggesting potential for growth at a reasonable price [5] - The Price to Book (P/B) ratio is 13.31, indicating that Netflix may be overvalued in terms of book value compared to its peers [5] - The Price to Sales (P/S) ratio of 8.03 is 1.86x higher than the industry average, which may also suggest overvaluation in sales performance [5] - The Return on Equity (ROE) is 9.2%, slightly above the industry average, indicating efficient use of equity to generate profits [5] - Netflix's EBITDA is $7.37 billion, which is 6.82x above the industry average, highlighting strong profitability and cash flow generation [5] - The gross profit of $5.35 billion is 2.88x above the industry average, indicating robust earnings from core operations [5] - Revenue growth of 4.7% is significantly higher than the industry average of 1.07%, showcasing strong demand for Netflix's offerings [5] Debt Management - Netflix has a debt-to-equity (D/E) ratio of 0.54, which is lower than that of its top four peers, indicating a stronger financial position and a favorable balance between debt and equity [9]

Core Insights - Marcus & Millichap has announced new regional leadership titles across the U.S. and Canada, indicating a strategic restructuring to enhance operational efficiency and market responsiveness [1] Group 1 - The company aims to strengthen its leadership framework to better serve clients and adapt to market changes [1] - This leadership change reflects the company's commitment to growth and innovation within the real estate investment sector [1] - The new titles are expected to empower regional leaders, allowing for more localized decision-making and improved service delivery [1]

Core Insights - Marcus Hotels & Resorts has opened The Marc Hotel, an independent 175-room hotel located in downtown Milwaukee, connected to the Baird Center via a climate-controlled skywalk [1][2] - The hotel aims to provide comfort and convenience for guests, featuring well-appointed rooms, convenient workspaces, and access to nearby dining and event spaces [2][3] - The Marc Hotel is a rebranding of the former west wing of Hilton Milwaukee, returning to its historical roots as the Marc Plaza Hotel, which was renamed in 1995 [4] Company Overview - Marcus Hotels & Resorts will manage 17 hotels and properties across the U.S., including city-center meeting hotels and upscale resorts, showcasing a diverse portfolio [6] - The company has been a leader in the hospitality industry since 1962, focusing on asset value creation through management and development expertise [6] - Marcus Corporation, the parent company, is also a significant player in the entertainment industry, operating the fourth largest theatre circuit in the U.S. with 985 screens across 78 locations [7]

Core Insights - Marcus & Millichap's IPA Capital Markets has successfully arranged $93.5 million in financing for the conversion of an office building into residential units in Manhattan [1] Group 1 - The financing will support the transformation of an office space into a mixed-use residential property, highlighting the trend of repurposing commercial real estate in urban areas [1] - This transaction reflects the growing demand for affordable housing solutions in metropolitan regions, particularly in New York City [1] - The financing amount of $93.5 million indicates significant investor confidence in the potential of the Manhattan real estate market [1]